
John D. Pak
Examiner (ID: 5837, Phone: (571)272-0620 , Office: P/1616 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 2899, 1616, 1209, 1699, 1621 |
| Total Applications | 2719 |
| Issued Applications | 1510 |
| Pending Applications | 255 |
| Abandoned Applications | 976 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16809515
[patent_doc_number] => 20210132069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => METHODS OF DETECTING PROGESTERONE RECEPTOR AND OF DETECTING AN EXPRESSION LEVEL
[patent_app_type] => utility
[patent_app_number] => 17/147151
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17147151
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/147151 | METHODS OF DETECTING PROGESTERONE RECEPTOR AND OF DETECTING AN EXPRESSION LEVEL | Jan 11, 2021 | Pending |
Array
(
[id] => 17053600
[patent_doc_number] => 20210263034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => DATA PROCESSING SYSTEM FOR IDENTIFYING A THERAPEUTIC AGENT
[patent_app_type] => utility
[patent_app_number] => 17/144108
[patent_app_country] => US
[patent_app_date] => 2021-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144108
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/144108 | DATA PROCESSING SYSTEM FOR IDENTIFYING A THERAPEUTIC AGENT | Jan 6, 2021 | Abandoned |
Array
(
[id] => 17214895
[patent_doc_number] => 20210348232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/140716
[patent_app_country] => US
[patent_app_date] => 2021-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17140716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/140716 | GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF | Jan 3, 2021 | Abandoned |
Array
(
[id] => 16948535
[patent_doc_number] => 20210207226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => DNA BARCODING-BASED METHOD FOR RAPID IDENTIFICATION OF LYCIUM CHINENSIS
[patent_app_type] => utility
[patent_app_number] => 17/136208
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136208
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/136208 | DNA BARCODING-BASED METHOD FOR RAPID IDENTIFICATION OF LYCIUM CHINENSIS | Dec 28, 2020 | Abandoned |
Array
(
[id] => 16917677
[patent_doc_number] => 20210190769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => DISTINGUISHING CANCER FROM NEUROLOGICAL RISK USING COPY NUMBER VARIATION
[patent_app_type] => utility
[patent_app_number] => 17/128446
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17128446
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/128446 | DISTINGUISHING CANCER FROM NEUROLOGICAL RISK USING COPY NUMBER VARIATION | Dec 20, 2020 | Abandoned |
Array
(
[id] => 18739985
[patent_doc_number] => 20230348955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => METHODS OF PRODUCING TARGET CAPTURE NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/783927
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783927
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/783927 | METHODS OF PRODUCING TARGET CAPTURE NUCLEIC ACIDS | Dec 17, 2020 | Pending |
Array
(
[id] => 16920171
[patent_doc_number] => 20210193263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => DESIGNING PROBES FOR DEPLETING ABUNDANT TRANSCRIPTS
[patent_app_type] => utility
[patent_app_number] => 17/125378
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/125378 | DESIGNING PROBES FOR DEPLETING ABUNDANT TRANSCRIPTS | Dec 16, 2020 | Abandoned |
Array
(
[id] => 18109930
[patent_doc_number] => 20230002810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => Method for Carrying Out an Amplification Reaction in a Microfluidic Apparatus
[patent_app_type] => utility
[patent_app_number] => 17/757132
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/757132 | Method for Carrying Out an Amplification Reaction in a Microfluidic Apparatus | Dec 9, 2020 | Pending |
Array
(
[id] => 18169119
[patent_doc_number] => 20230035730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => SOLUBLE CD28 LEVELS DURING IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/781966
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781966 | SOLUBLE CD28 LEVELS DURING IMMUNOTHERAPY | Dec 1, 2020 | Pending |
Array
(
[id] => 18825459
[patent_doc_number] => 11840730
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-12
[patent_title] => Methods and compositions for evaluating genetic markers
[patent_app_type] => utility
[patent_app_number] => 16/952764
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 30089
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952764
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952764 | Methods and compositions for evaluating genetic markers | Nov 18, 2020 | Issued |
Array
(
[id] => 17867413
[patent_doc_number] => 20220290149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => METHOD OF DETECTION OF FIBRIN CLOTS
[patent_app_type] => utility
[patent_app_number] => 17/770241
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/770241 | METHOD OF DETECTION OF FIBRIN CLOTS | Nov 11, 2020 | Abandoned |
Array
(
[id] => 16621900
[patent_doc_number] => 20210040553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => OLIGONUCLEOTIDE FRAGMENT, AND METHOD AS WELL AS APPLICATION OF SELECTIVE AMPLIFICATION OF VARIANT OF TARGET NUCLEIC ACID SEQUENCE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/083595
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083595
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083595 | OLIGONUCLEOTIDE FRAGMENT, AND METHOD AS WELL AS APPLICATION OF SELECTIVE AMPLIFICATION OF VARIANT OF TARGET NUCLEIC ACID SEQUENCE USING THE SAME | Oct 28, 2020 | Abandoned |
Array
(
[id] => 16778422
[patent_doc_number] => 20210115500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => GENOTYPING EDITED MICROBIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/072449
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072449
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/072449 | GENOTYPING EDITED MICROBIAL STRAINS | Oct 15, 2020 | Abandoned |
Array
(
[id] => 17082475
[patent_doc_number] => 20210277481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => CIRCULATING TUMOR AND TUMOR STEM CELL DETECTION USING GENOMIC SPECIFIC PROBES
[patent_app_type] => utility
[patent_app_number] => 17/061412
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061412
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/061412 | CIRCULATING TUMOR AND TUMOR STEM CELL DETECTION USING GENOMIC SPECIFIC PROBES | Sep 30, 2020 | Abandoned |
Array
(
[id] => 16720482
[patent_doc_number] => 20210087629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => Methods for Treating and Detecting Sepsis in Humans
[patent_app_type] => utility
[patent_app_number] => 17/038496
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17038496
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/038496 | Methods for Treating and Detecting Sepsis in Humans | Sep 29, 2020 | Abandoned |
Array
(
[id] => 16728186
[patent_doc_number] => 20210095333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => QUANTIFICATION OF MOLECULES USING NUCLEIC ACID STRAND DISPLACEMENT DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/039956
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17039956
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/039956 | QUANTIFICATION OF MOLECULES USING NUCLEIC ACID STRAND DISPLACEMENT DETECTION | Sep 29, 2020 | Abandoned |
Array
(
[id] => 16728204
[patent_doc_number] => 20210095351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => Methods of Preparing Dual Indexed Methyl-Seq Libraries
[patent_app_type] => utility
[patent_app_number] => 17/036986
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17036986
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/036986 | Methods of Preparing Dual Indexed Methyl-Seq Libraries | Sep 28, 2020 | Pending |
Array
(
[id] => 17930146
[patent_doc_number] => 20220325271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => DROPLET-BASED SINGLE EXTRACELLULAR VESICLE SEQUENCING
[patent_app_type] => utility
[patent_app_number] => 17/765145
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765145
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/765145 | DROPLET-BASED SINGLE EXTRACELLULAR VESICLE SEQUENCING | Sep 27, 2020 | Pending |
Array
(
[id] => 16541369
[patent_doc_number] => 20200407782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => METHODS OF DETECTING NUCLEIC ACIDS IN INDIVIDUAL CELLS AND OF IDENTIFYING RARE CELLS FROM LARGE HETEROGENEOUS CELL POPULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/012394
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012394
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/012394 | METHODS OF DETECTING NUCLEIC ACIDS IN INDIVIDUAL CELLS AND OF IDENTIFYING RARE CELLS FROM LARGE HETEROGENEOUS CELL POPULATIONS | Sep 3, 2020 | Abandoned |
Array
(
[id] => 17853120
[patent_doc_number] => 20220283162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => MCM5 ELISA FOR THE DETECTION OF RECURRENT BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 17/634579
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634579
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/634579 | MCM5 ELISA FOR THE DETECTION OF RECURRENT BLADDER CANCER | Aug 31, 2020 | Abandoned |